Cargando…
Perspectives of ERCC1 in early-stage and advanced cervical cancer: From experiments to clinical applications
Cervical cancer is a public health problem of extensive clinical importance. Excision repair cross-complementation group 1 (ERCC1) was found to be a promising biomarker of cervical cancer over the years. At present, there is no relevant review article that summarizes such evidence. In this review, n...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9875293/ https://www.ncbi.nlm.nih.gov/pubmed/36713431 http://dx.doi.org/10.3389/fimmu.2022.1065379 |